Arginase 1 (ARG1) blockade in combination with immune checkpoint inhibitors promotes CD8+ T cells in pancreatic ductal adenocarcinoma (PDAC) in vitro [166]. This evidence concerns the gene ARG1 and pancreatic ductal adenocarcinoma.